Myo‐Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study
Journal of Inherited Metabolic Disease · 2025
DOI: 10.1002/jimd.70097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Eva Niess und 15 weiteren Autor:innen. Beteiligte Einrichtung: High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Galactosemias, Inositol, Brain, Cerebrovascular Circulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, H2020 Marie Skłodowska-Curie Actions, Galactosemia Foundation.
Abstract (Originalsprache)
Classic galactosemia is a rare metabolic disorder resulting from galactose‐1‐phosphate uridylyltransferase deficiency, which disrupts normal galactose metabolism, leading to toxic accumulation of galactose‐1‐phosphate and galactitol. Despite early dietary intervention, patients remain at risk for long‐term neurological impairments, including cognitive deficits, motor speech disorders, and psychiatric conditions. The mechanisms driving these persistent abnormalities remain unclear. This study investigated brain metabolic and structural alterations in adults with classic galactosemia using advanced multiparametric MRI. Six patients (3 males, 3 females; mean age 34.0 ± 7.3 years) adhering to lifelong galactose‐restricted diets and six age‐ and sex‐matched controls underwent 3T and 7T MRI, including T1‐weighted imaging, pseudo‐continuous arterial spin labeling, and high‐resolution MR spectroscopic imaging. Patients exhibited significantly lower myo‐inositol (mIns) concentrations in cerebellum ( p = 0.007), putamen ( p = 0.023), and cerebral white matter ( p = 0.001), reflecting a chronic mIns deficiency despite dietary management. Structural analyses revealed reduced volumes of white matter ( p < 0.001), bilateral putamen ( p < 0.038), and left thalamus ( p = 0.044); alongside increased cortical thickness and reduced cortical surface area, indicating abnormal cortical maturation, particularly in regions associated with motor and cognitive processing. Additionally, cerebral blood flow was elevated in emotion‐processing regions, including bilateral amygdala ( p < 0.022) and thalamus ( p < 0.038). These preliminary findings highlight persistent neurological alterations in classic galactosemia despite dietary management and suggest that chronic mIns deficiency may contribute to the pathophysiology. They underscore the need for larger, longitudinal studies to confirm these results, investigate potential correlations with clinical severity and biochemical markers, and explore therapeutic strategies aimed at modulating mIns metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
- Christian Doppler Laboratory for MR Imaging Biomarkers (BIOMAK), Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
- Danish Research Centre for Magnetic Resonance, Department of Radiology and Nuclear Medicine, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.
- Department of Radiology and Nuclear Medicine, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.
- Division of Pediatric Pulmonology, Allergology and Endocrinology, Austrian Newborn Screening, Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
- Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Eva Niess, Fabian Niess, Wolfgang Bogner, Marion Herle, Maximilian Pichler, Alexandra Kautzky-Willer
Förderung
- Austrian Science Fund
- H2020 Marie Skłodowska-Curie Actions
- Galactosemia Foundation
Zitieren
APA
Niess, E., Niess, F., Bogner, W., Svatkova, A., Herle, M., Laußner, L., Hingerl, L., Strasser, B., Pichler, M., Konstantopoulou, V., Hufgard-Leitner, M., Buchinger, D., Milenkovic, I., Kautzky-Willer, A., Stulnig, T., & Scherer, T. (2025). Myo‐Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70097
Vancouver
Niess E, Niess F, Bogner W, Svatkova A, Herle M, Laußner L, et al. Myo‐Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70097
BibTeX
@article{Niess2025,
author = {Niess, Eva and Niess, Fabian and Bogner, Wolfgang and Svatkova, Alena and Herle, Marion and Laußner, Lisa and Hingerl, Lukas and Strasser, Bernhard and Pichler, Maximilian and Konstantopoulou, Vassiliki and Hufgard-Leitner, Miriam and Buchinger, Dominic and Milenkovic, Ivan and Kautzky-Willer, Alexandra and Stulnig, Thomas and Scherer, Thomas},
title = {Myo‐Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study},
journal = {Journal of Inherited Metabolic Disease},
year = {2025},
doi = {10.1002/jimd.70097}
}
EUVIMED